Premium
NewAmsterdam Pharma Company NV (NAMS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, LP | Institution | 16 943 774 | 14,49% | US$ 496,96M | 2026-03-31 |
| Capital Research and Management Company | Institution | 12 188 377 | 10,43% | US$ 357,49M | 2026-05-29 |
| RA Capital Management, L.P. | Institution | 9 550 191 | 8,17% | US$ 280,11M | 2026-03-31 |
| Forbion Capital Partners B.V. | Institution | 9 198 900 | 7,87% | US$ 269,80M | 2026-03-31 |
| FMR LLC | Institution | 8 765 811 | 7,50% | US$ 257,10M | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 8 623 939 | 7,38% | US$ 252,94M | 2025-11-01 |
| Wellington Management Group LLP | Institution | 5 115 818 | 4,38% | US$ 150,05M | 2026-03-31 |
| Forbion IV | Institution | 4 668 889 | 3,99% | US$ 136,94M | 2025-09-26 |
| Forbion Growth Opportunities Fund I | Institution | 4 648 025 | 3,98% | US$ 136,33M | 2025-09-26 |
| Deerfield Management Company, L.P. | Institution | 4 264 789 | 3,65% | US$ 125,09M | 2026-03-31 |
| Viking Global Investors LP | Institution | 4 203 567 | 3,60% | US$ 123,29M | 2026-03-31 |
| Duquesne Family Office LLC | Institution | 3 070 146 | 2,63% | US$ 90,05M | 2026-03-31 |
| Frazier Life Sciences X, L.P. | Institution | 3 028 524 | 2,59% | US$ 88,83M | 2025-11-01 |
| Polar Capital Holdings Plc | Institution | 2 831 607 | 2,42% | US$ 83,05M | 2026-03-31 |
| Jennison Associates LLC | Institution | 2 750 403 | 2,35% | US$ 80,67M | 2026-03-31 |
| Medicxi Ventures (UK) LLP | Institution | 2 674 182 | 2,29% | US$ 78,43M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 2 258 984 | 1,93% | US$ 66,26M | 2026-03-31 |
| Westfield Capital Management Company, L.P. | Institution | 2 202 913 | 1,88% | US$ 64,61M | 2026-03-31 |
| Maverick Capital, Ltd. | Institution | 2 186 402 | 1,87% | US$ 64,13M | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | Institution | 2 173 913 | 1,86% | US$ 63,76M | 2026-05-12 |
| Bain Capital Life Sciences Fund III, L.P. | Institution | 2 059 896 | 1,76% | US$ 60,42M | 2026-05-12 |
| The Goldman Sachs Group, Inc. | Institution | 1 946 374 | 1,66% | US$ 57,09M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 1 199 325 | 1,03% | US$ 35,18M | 2026-03-31 |
| Frazier Life Sciences XI, L.P. | Institution | 1 179 926 | 1,01% | US$ 34,61M | 2025-11-01 |
| Norges Bank Investment Management | Institution | 1 135 195 | 0,97% | US$ 33,30M | 2025-12-31 |
| Adage Capital Management, L.P. | Institution | 1 106 631 | 0,95% | US$ 32,46M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1 080 261 | 0,92% | US$ 31,68M | 2026-03-31 |
| Castle Hook Partners LP | Institution | 1 042 637 | 0,89% | US$ 30,58M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 950 000 | 0,81% | US$ 27,86M | 2026-03-31 |
| BlackRock, Inc. | Institution | 886 616 | 0,76% | US$ 26,00M | 2026-03-31 |
| JP Morgan Asset Management | Institution | 856 417 | 0,73% | US$ 25,12M | 2026-03-31 |
| Aberdeen Group Plc | Institution | 837 005 | 0,72% | US$ 24,55M | 2026-03-31 |
| BNPP Asset Management Holding | Institution | 782 183 | 0,67% | US$ 22,94M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 761 786 | 0,65% | US$ 22,34M | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 753 054 | 0,64% | US$ 22,09M | 2026-03-31 |
| Woodline Partners LP | Institution | 752 308 | 0,64% | US$ 22,07M | 2026-03-31 |
| TimesSquare Capital Management, LLC | Institution | 751 988 | 0,64% | US$ 22,06M | 2026-03-31 |
| Bank of America Corporation | Institution | 745 670 | 0,64% | US$ 21,87M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 712 064 | 0,61% | US$ 20,88M | 2026-03-31 |
| NWI Management LP | Institution | 702 000 | 0,60% | US$ 20,59M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
